Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $13.11 $15.83 Friday, 10th May 2024 SRRK stock ended at $13.35. This is 8.25% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.97% from a day low at $13.19 to a day high of $14.37.
90 days $12.81 $17.90
52 weeks $5.56 $21.17

Historical Scholar Rock Holding Corp. prices

Date Open High Low Close Volume
Dec 15, 2023 $19.28 $19.91 $18.32 $18.98 5 138 775
Dec 14, 2023 $19.04 $19.46 $17.42 $18.56 2 202 050
Dec 13, 2023 $18.75 $19.83 $18.49 $19.47 1 667 487
Dec 12, 2023 $18.07 $19.37 $17.87 $18.50 1 130 217
Dec 11, 2023 $18.44 $18.51 $17.48 $18.07 890 017
Dec 08, 2023 $17.91 $19.52 $17.88 $18.25 1 672 354
Dec 07, 2023 $16.00 $17.56 $15.80 $17.55 838 445
Dec 06, 2023 $15.50 $16.36 $15.32 $15.93 790 662
Dec 05, 2023 $14.38 $15.75 $14.38 $15.55 1 793 118
Dec 04, 2023 $13.53 $14.57 $13.50 $14.50 1 151 831
Dec 01, 2023 $12.58 $13.64 $12.21 $13.45 1 144 391
Nov 30, 2023 $12.38 $12.88 $12.30 $12.59 1 212 701
Nov 29, 2023 $11.70 $12.14 $11.49 $12.09 684 064
Nov 28, 2023 $11.97 $11.97 $11.52 $11.63 307 340
Nov 27, 2023 $11.63 $12.04 $11.55 $11.97 429 167
Nov 24, 2023 $11.41 $11.85 $11.32 $11.74 264 319
Nov 22, 2023 $11.97 $12.18 $10.90 $11.33 668 709
Nov 21, 2023 $11.13 $11.96 $10.54 $11.86 479 528
Nov 20, 2023 $12.19 $12.34 $11.69 $11.75 559 663
Nov 17, 2023 $11.85 $12.28 $11.52 $12.13 451 811
Nov 16, 2023 $11.93 $12.23 $11.67 $11.76 585 976
Nov 15, 2023 $11.07 $12.05 $11.07 $11.88 774 462
Nov 14, 2023 $10.23 $11.08 $10.20 $11.05 752 879
Nov 13, 2023 $9.94 $10.00 $9.16 $9.88 560 822
Nov 10, 2023 $10.19 $10.19 $9.48 $10.05 878 207
Click to get the best stock tips daily for free!

About Scholar Rock Holding Corp.

Scholar Rock Holding . Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical tria... SRRK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT